Clinical trial
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
NCT03821857 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 27, 2019
- Completion date
- May 31, 2030
- Enrollment
- 614 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.